5.11 USD
↗ 0.54 (11.82%)AT CLOSE (11:59 AM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock
ZNTLNASDAQ • USD
5.08
↘ 0.03 (0.61%)
POST MARKET (AS OF 05:25 PM EDT)
Post Market
AS OF 05:25 PM EDT
5.08
↘ 0.03 (0.61%)
Market: OPEN
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $4.82. ZNTL shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jul 17, 2026.
Open?$4.68
High?$5.34
Low?$4.68
Prev. Close?$4.57
Volume?3.6M
Avg. Volume?1.2M
VWAP?$5.07
Rel. Volume?2.93x
Bid / Ask
Bid?$4.31 × 100
Ask?$6.05 × 100
Spread?$1.74
Midpoint?$5.18
Valuation & Ratios
Market Cap?325.3M
Shares Out?71.2M
Float?46.7M
Float %?64.6%
P/E Ratio?N/A
P/B Ratio?1.78
EPS?-$1.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
325.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.04Distress
Confidence?56%Low
Short InterestHigh
Short % of Float?12.58%High
Short Interest?5.9M
Days to Cover?3.2
Free Float46.7M
Avg Daily Volume1.8M
Settlement Date2026-06-30
Financial Health
Current Ratio?6.19Strong
Quick Ratio?6.19Strong
Cash Ratio?0.91Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.78CHEAP▾
Peers100
S&P80
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-68.0%WEAK▾
S&P3
ROA?-49.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-125601000
Enterprise Value?$293.4M
Fundamentals ratios updated end of day